United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies
The biopsy is the procedure to collect the tissues or fluid from the area, which has grown abnormally over a period of time. The sample (tissue or fluid) is further examined through the microscope to check the presence of cancer. Different types of biopsy are done to know cancer, such as vacuum-assisted biopsy, fine-needle aspiration biopsy, and core needle biopsy. For colorectal cancer, colonoscopy or endoscopy is primarily done to check abnormalities, and during the process, abnormal tissues called polyps would collect for biopsy. In the United States, overall cancer incidence is rising, but the cancer death rate is falling over the period of time because of the rise in the number of cancer diagnostics, especially biopsy screening for cancer. United States Biopsy Market is expected to cross US$ 14 Billion mark by the end of the year 2025.
The essential factors that will fuel the market growth are; the rise of an ageing population in the United States, continuous improvement of healthcare infrastructure, rising per capita health care expenditure, increasing per capita income, growing awareness about early detection of cancer by several screening including biopsy, improvement of diagnostic technologies, etc. Moreover, the rising incidence of cancer in the United States and increase of less invasive procedures during biopsy will further propel the United States biopsy market in the future course of time.
Renub Research report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)” provides a complete analysis of the United States Biopsy Market and Volume.
United States Biopsy Volume Insights - Breast Cancer Biopsy is holding the largest Volume Share
In this report, we have fragmented cancer by biopsy volume into 8 parts; Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Skin Cancer. Breast cancer biopsy is holding the largest volume share of cancer biopsy in the United States. This report provides a multifactor analysis of why biopsy volume is rising in the United States.
United States Biopsy Market Insights
In this report, we have categorized the biopsy market into 8 parts by cancer type; Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Skin Cancer. For many cancer, more than one biopsy is required to diagnose the patients like colorectal cancer requires at least 6 biopsies. Besides, we have also explained the growth driver and challenges of the biopsy market in the United States.
United States New Cases of Cancer Diagnostic Insights
In this report, we have shown new cancer diagnostic cases and also providing the factor by which cancer prevalence is increasing or decreasing over a period of time.
Segments Covered in the Report
• Breast Cancer Biopsy
• Prostate Cancer Biopsy
• Lung Cancer Biopsy
• Liver Cancer Biopsy
• Thyroid Cancer Biopsy
• Kidney Cancer Biopsy
• Colorectal Cancer Biopsy
• Skin Cancer Biopsy
Key Companies Covered in the Report
• C. R. Bard, Inc.
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• Olympus Corporation
• FUJIFILM Holdings Corporation
• Medtronic plc.
• Hologic, Inc
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook